Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) Director Joseph S. Konowiecki sold 6,920 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $13.73, for a total value of $95,011.60. Following the transaction, the director now owns 1,134,888 shares in the company, valued at approximately $15,582,012.24. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Alignment Healthcare Trading Down 2.9 %
Shares of ALHC opened at $12.78 on Thursday. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $14.25. The firm has a market cap of $2.45 billion, a price-to-earnings ratio of -16.60 and a beta of 1.45. The business's fifty day moving average is $11.49 and its 200-day moving average is $9.28.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.14). The firm had revenue of $692.43 million for the quarter, compared to analysts' expectations of $662.11 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business's revenue for the quarter was up 51.6% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.19) earnings per share. Equities analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.
Hedge Funds Weigh In On Alignment Healthcare
Bill Gates’ is about to mint millionaires (again) with Stargate.
From Brownstone Research | Ad
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS.
But what’s even more unbelievable?
I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.
Click here and I’ll tell you everything you need to know.
Several institutional investors and hedge funds have recently added to or reduced their stakes in ALHC. Virtu Financial LLC bought a new stake in shares of Alignment Healthcare during the first quarter worth $57,000. nVerses Capital LLC acquired a new stake in shares of Alignment Healthcare during the 3rd quarter valued at $95,000. Principal Financial Group Inc. grew its position in Alignment Healthcare by 18.1% during the 2nd quarter. Principal Financial Group Inc. now owns 13,521 shares of the company's stock worth $106,000 after acquiring an additional 2,077 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Alignment Healthcare in the 3rd quarter worth about $131,000. Finally, Creative Planning raised its position in Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company's stock valued at $147,000 after purchasing an additional 2,072 shares during the last quarter. Institutional investors own 86.19% of the company's stock.
Wall Street Analysts Forecast Growth
ALHC has been the subject of a number of recent research reports. KeyCorp assumed coverage on shares of Alignment Healthcare in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. Robert W. Baird boosted their price objective on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an "outperform" rating in a report on Wednesday, August 14th. Piper Sandler reaffirmed an "overweight" rating and set a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. UBS Group boosted their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a research note on Wednesday, October 30th. Finally, Barclays raised their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, three have given a hold rating, six have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $10.33.
Check Out Our Latest Research Report on ALHC
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
